Literature DB >> 15373901

CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.

I V Lyadova1, S Oberdorf, M A Kapina, A S Apt, S L Swain, P C Sayles.   

Abstract

Protection against tuberculosis depends upon the generation of CD4(+) T cell effectors capable of producing IFN-gamma and stimulating macrophage antimycobacterial function. Effector CD4(+) T cells are known to express CD44(hi)CD62L(lo) surface phenotype. In this paper we demonstrate that a population of CD44(hi)CD62L(lo) CD4(+) effectors generated in response to Mycobacterium bovis BCG or M. tuberculosis infection in C57BL/6 mice is heterogeneous and consists of CD27(hi) and CD27(lo) T cell subsets. These subsets exhibit a similar degree of in vivo proliferation, but differ by the capacity for IFN-gamma production. Ex vivo isolated CD27(lo) T cells express higher amounts of IFN-gamma RNA and contain higher frequencies of IFN-gamma producers compared to CD27(hi) subset, as shown by real-time PCR, intracellular staining for IFN-gamma and ELISPOT assays. In addition, CD27(lo) CD4(+) T cells uniformly express CD44(hi)CD62L(lo) phenotype. We propose that CD27(lo) CD44(hi)CD62L(lo) CD4(+) T cells represent highly differentiated effector cells with a high capacity for IFN-gamma secretion and antimycobacterial protection at the site of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373901      PMCID: PMC1809176          DOI: 10.1111/j.1365-2249.2004.02573.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.

Authors:  H Gudmundsdottir; A D Wells; L A Turka
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination.

Authors:  C L Silva; V L Bonato; V M Lima; L H Faccioli; S C Leão
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

3.  Helper T cell differentiation is controlled by the cell cycle.

Authors:  J J Bird; D R Brown; A C Mullen; N H Moskowitz; M A Mahowald; J R Sider; T F Gajewski; C R Wang; S L Reiner
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 6.  IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men.

Authors:  E Jouanguy; R Döffinger; S Dupuis; A Pallier; F Altare; J L Casanova
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

7.  Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis.

Authors:  C G Feng; A G Bean; H Hooi; H Briscoe; W J Britton
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis.

Authors:  I Lyadova; V Yeremeev; K Majorov; B Nikonenko; S Khaidukov; T Kondratieva; N Kobets; A Apt
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  11 in total

Review 1.  The physiological role of cytotoxic CD4(+) T-cells: the holy grail?

Authors:  V Appay
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

2.  Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis.

Authors:  Jing Jiang; Xianyuan Wang; Xinjing Wang; Zhihong Cao; Yanhua Liu; Mei Dong; Aihua Tong; Xiaoxing Cheng
Journal:  J Clin Immunol       Date:  2010-07       Impact factor: 8.317

3.  Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.

Authors:  Nacho Aguilo; Ana Maria Toledo; Eva Maria Lopez-Roman; Esther Perez-Herran; Eamonn Gormley; Joaquin Rullas-Trincado; Iñigo Angulo-Barturen; Carlos Martin
Journal:  Clin Vaccine Immunol       Date:  2014-02-05

4.  Targeting B-cell malignancies through human B-cell receptor specific CD4+ T cells.

Authors:  Jinsheng Weng; Flavio Egidio Baio; Kelsey E Moriarty; Hiroki Torikai; Hua Wang; Zhiqiang Liu; Sourindra N Maiti; Dongho Gwak; Michael S Popescu; Soung-Chul Cha; Laurence J N Cooper; Sattva S Neelapu; Larry W Kwak
Journal:  Oncoimmunology       Date:  2016-09-19       Impact factor: 8.110

5.  Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans.

Authors:  Irina Yu Nikitina; Natalya A Kondratuk; George A Kosmiadi; Rasul B Amansahedov; Irina A Vasilyeva; Vitaly V Ganusov; Irina V Lyadova
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

6.  Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge.

Authors:  Daryan A Kaveh; Véronique S Bachy; R Glyn Hewinson; Philip J Hogarth
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

Review 7.  Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis.

Authors:  Elisa Petruccioli; Thomas J Scriba; Linda Petrone; Mark Hatherill; Daniela M Cirillo; Simone A Joosten; Tom H Ottenhoff; Claudia M Denkinger; Delia Goletti
Journal:  Eur Respir J       Date:  2016-11-11       Impact factor: 16.671

8.  Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis.

Authors:  Mathias Streitz; Lydia Tesfa; Vedat Yildirim; Ali Yahyazadeh; Timo Ulrichs; Rodica Lenkei; Ali Quassem; Gerd Liebetrau; Laurel Nomura; Holden Maecker; Hans-Dieter Volk; Florian Kern
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240

Review 9.  Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers.

Authors:  I V Lyadova; A V Panteleev
Journal:  Mediators Inflamm       Date:  2015-11-10       Impact factor: 4.711

10.  CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.

Authors:  Fadel Sayes; Alexandre Pawlik; Wafa Frigui; Matthias I Gröschel; Samuel Crommelynck; Catherine Fayolle; Felipe Cia; Gregory J Bancroft; Daria Bottai; Claude Leclerc; Roland Brosch; Laleh Majlessi
Journal:  PLoS Pathog       Date:  2016-07-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.